CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8129
-0.0311 (-3.68%)
Nov 13, 2026, 10:17 AM EST - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $9.7 million as of November 13, 2026. It is the 41,292nd most valuable company in the world and the 5,540th biggest in the United States. Its market cap has decreased by 56.44% in one year.
Market Cap
9.70M
Enterprise Value
8.93M
1-Year Change
-56.44%
Global Rank
Country Rank
#5,540 United States
Category
ChartMarket Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $9.70M, a decrease of -78.96%. That is a compound annual growth rate of -35.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 9.70M | -37.02% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 11.45M |
| Vyome Holdings | 11.44M |
| TScan Therapeutics | 11.39M |
| Purple Biotech | 10.98M |
| Cellectar Biosciences | 10.96M |
| Fractyl Health | 10.77M |
| Addex Therapeutics | 10.47M |
| Chemomab Therapeutics | 10.14M |